Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.52
0.020.8%
At close: Sep 25, 5:00 PM EST
$2.58
0.05922.35%
After Hours: Sep 25, 6:50 PM EST
Perspective Therapeutics Inc (CATX) Stock Price, Quote, News & History
CATXAMEX
Perspective Therapeutics (CATX) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
FAQ
How do I buy Perspective Therapeutics (CATX) stock?
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Who are Perspective Therapeutics (CATX) competitors?
Other companies in Perspective Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Perspective Therapeutics (CATX) stock?
Perspective Therapeutics has a consensus price target of $12.81.
What is the current price for Perspective Therapeutics (CATX)?
The stock price for Perspective Therapeutics (AMEX: CATX) is $2.5792 last updated September 25, 2026 at 6:50 PM EDT.
Does Perspective Therapeutics (CATX) pay a dividend?
There are no upcoming dividends for Perspective Therapeutics.
When is Perspective Therapeutics (AMEX:CATX) reporting earnings?
Perspective Therapeutics does not have any upcoming earnings scheduled.
Is Perspective Therapeutics (CATX) going to split?
There is no upcoming split for Perspective Therapeutics.
What sector and industry does Perspective Therapeutics (CATX) operate in?
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
